ACC clears Dr Rajeev Singh Raghuvanshi’s reappointment as Drugs Controller (India)

Dr Rajeev Singh Raghuvanshi will continue as Drugs Controller (India) at CDSCO. His reappointment is on a contract basis for one year starting March 1, 2026. This decision follows a proposal from the Department of Health and Family Welfare. Dr Raghuvanshi heads the CDSCO, responsible for drug quality and new drug approvals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8FeGzSH
via IFTTT